Skip to main content
Clinical Trials/NCT01514006
NCT01514006
Completed
Not Applicable

Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty - a Prospective Observational Study

Rigshospitalet, Denmark2 sites in 1 country125 target enrollmentJanuary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arthroplasty, Hip Replacement
Sponsor
Rigshospitalet, Denmark
Enrollment
125
Locations
2
Primary Endpoint
6 Minute walking test (6MWT)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the possible association between postoperative anaemia and functional outcomes the first 2 weeks after primary hip arthroplasty.

The investigators hypothesise that patients with a higher degree of postoperative anaemia have impaired postoperative rehabilitation as measured by standardized functional outcome tests.

Detailed Description

Postoperative anemia may impair postoperative rehabilitation due to anemia related symptoms such as fatigue or dizziness. Although, the impact of postoperative anemia on postoperative rehabilitation and function has previously been examined the results are conflicting. Patients undergoing fast-track hip arthroplasty (THA) are mobilized early and participate in physiotherapy during the admission but are discharged early (2-3) days postoperative. However, the ability to rehabilitate early after discharge has not been evaluated in relation to postoperative anemia. The purpose of this observational study is to evaluate the possible association between postoperative anaemia and functional outcomes the first 2 weeks after primary hip arthroplasty. The investigators hypothesise that patients with a higher degree of postoperative anaemia have impaired postoperative rehabilitation as measured by standardized functional outcome tests. Hb concentrations and functional outcome measurements will be performed preoperatively, at the day of hospital discharge and during a postoperative visit 12-16 days after surgery.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
August 2013
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Oeivind Jans

MD., Research Fellow

Rigshospitalet, Denmark

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing primary unilateral THA
  • Age 65 or older

Exclusion Criteria

  • Not able to give consent
  • Not able to walk prior to surgery
  • Chronic need for RBC transfusion

Outcomes

Primary Outcomes

6 Minute walking test (6MWT)

Time Frame: 2 weeks after surgery

6MWT is a standardized functional test which determines the walking distance covered during a timed period of 6 minutes.

Secondary Outcomes

  • FACT-Anemia Scale(2 weeks after surgery)
  • At home activity by ActivPal(1 week after surgery)
  • Timed up and go test (TUG)(2 weeks after surgery)

Study Sites (2)

Loading locations...

Similar Trials